Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 92.50M | £ 82.80M | £ 34.60M | £ 150.50M | £ 137.80M |
Total Assets | £ 815.80M | £ 819.10M | £ 819.80M | £ 1.23B | £ 1.30B |
Total Debt | £ 373.00M | £ 371.50M | £ 375.60M | £ 715.30M | £ 715.10M |
Net Debt | £ 280.50M | £ 288.70M | £ 341.00M | £ 564.80M | £ 577.30M |
Total Liabilities | £ 406.30M | £ 405.00M | £ 417.70M | £ 765.50M | £ 777.80M |
Stockholders Equity | £ 409.50M | £ 414.10M | £ 402.10M | £ 460.40M | £ 518.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |